News & Press

Friday, February 12th, 2010

Great expectations—Isconova to receive the 2010 Bona Postulata Prize

Monday, November 23rd, 2009

Study shows that Isconova´s Matrix-M is an excellent pandemic influenza vaccine candidate

Monday, August 24th, 2009

Isconova AB appoints Lena Söderström as new CEO

Monday, July 20th, 2009

Isconova reaches milestone in influenza vaccine collaboration

Thursday, January 22nd, 2009

Two cornerstone patent applications granted in Europe

Wednesday, December 24th, 2008

Isconova Announces New Board Member

Saturday, November 1st, 2008

Isconova signs distribution agreement with Biogenuix Medsystems Pvt. Ltd.

Thursday, August 28th, 2008

Meet Isconova at Biopartnering Europe Oct 13-14 in London

Wednesday, August 27th, 2008

Isconova secures 30 million Swedish kronor growth financing

Wednesday, September 26th, 2007

Isconova announces New board of Directors (in Swedish only)